ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

PRAX Praxis Precision Medicines Inc

54.54
0.38 (0.70%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Praxis Precision Medicines Inc PRAX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.38 0.70% 54.54 06:30:00
始値 安値 高値 終値 前日終値
55.40 54.345 55.435 54.54 54.16
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1221:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
2024/3/0523:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/3/0521:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0521:13EDGAR2Form 8-K - Current report
2024/3/0521:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1510:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1500:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1409:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0106:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/1806:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1307:23EDGAR2Form 8-K - Current report
2024/1/1307:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1120:01EDGAR2Form 8-K - Current report
2024/1/1107:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1106:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
2024/1/1106:10EDGAR2Form 8-K - Current report
2024/1/1011:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1011:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1011:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1011:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0807:23EDGAR2Form 8-K - Current report
2023/12/0807:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0206:33EDGAR2Form 8-K - Current report
2023/11/2821:00GLOBEPraxis Precision Medicines to Showcase Largest Pipeline of..
2023/11/2206:00GLOBEPraxis Precision Medicines to Present at the Piper Sandler..
2023/11/1622:00GLOBEPraxis Precision Medicines Receives PRIME Designation from..
2023/11/0721:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:35EDGAR2Form 8-K - Current report
2023/11/0721:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
2023/11/0706:24EDGAR2Form 8-K - Current report
2023/11/0221:00GLOBEPraxis Precision Medicines to Present at Truist Securities..
2023/10/1620:09EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/1020:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0420:56EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/10/0302:27EDGAR2Form 8-K - Current report
2023/10/0302:17GLOBEPraxis Precision Medicines Provides Portfolio Update at 2023..
2023/9/2805:15GLOBEPraxis Precision Medicines To Host Hybrid R&D Day on Monday,..
2023/9/1923:25APSBiotech Catches Major Premarket Bid
2023/9/0721:00GLOBEPraxis Precision Medicines to Present at H.C. Wainwright..
2023/8/3121:00GLOBEPraxis Precision Medicines to Present Data from Epilepsy..
2023/8/0921:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0921:27EDGAR2Form 8-K - Current report
2023/8/0920:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
2023/8/0820:00GLOBEPraxis Precision Medicines Announces Positive Data from..
2023/8/0720:00GLOBEPraxis Precision Medicines Announces Positive Results of EEG..

最近閲覧した銘柄

Delayed Upgrade Clock